Kenneth Roberts
Physician Assistant · Ormond Beach, FLNPI 1285748954
Payments from drug & device makers
Across 138 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$523
- Sumitomo Pharma America, Inc.$387
- Pfizer$332
- AbbVie$260
- Teleflex LLC$187
- Myriad Genetic Laboratories, Inc.$186
- plus $812 from 20 others
What the payments were for
- Food & beverage$2,52294%
- Education$1656%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 35 | $523 |
| Sumitomo Pharma America, Inc. | 17 | $387 |
| Pfizer | 11 | $332 |
| AbbVie | 15 | $260 |
| Teleflex LLC | 7 | $187 |
| Myriad Genetic Laboratories, Inc. | 10 | $186 |
| Myovant Sciences Inc. | 6 | $106 |
| Tolmar, Inc. | 4 | $97 |
| Antares Pharma, Inc. | 5 | $94 |
| Progenics Pharmaceuticals, Inc. | 3 | $76 |
| Urovant Sciences Inc | 4 | $68 |
| Coloplast | 3 | $52 |
| Clarus Therapeutics Inc. | 3 | $44 |
| Medtronic | 2 | $40 |
| Endo Pharmaceuticals Inc. | 2 | $28 |
| Halozyme Inc | 1 | $23 |
| Novartis | 1 | $22 |
| Bayer | 1 | $22 |
| Rochester Medical Corporation | 1 | $21 |
| Blue Earth Diagnostics | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Immunitybio, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Olympus America Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
How this compares
$2,687 in reported general payments places this provider in the 80th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 21 | $55,942 |
| MyrbetriqMirabegron | 27 | $27,293 |
| Tamsulosin Hcl | 238 | $4,155 |
| Silodosin | 23 | $2,124 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 31 | $1,172 |
| Oxybutynin Chloride ErOxybutynin Chloride | 26 | $651 |
| Cefadroxil | 35 | $532 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $530 |
| Ciprofloxacin Hcl | 40 | $437 |
| Doxazosin Mesylate | 20 | $423 |
| Finasteride | 29 | $419 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 28 | $398 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $316 |
| Cephalexin | 23 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $387 | $55,94221 claims |
| Astellas Pharma US IncMyrbetriq | $523 | $27,29327 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Ormond Beach
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.